These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 28647031)
1. Cover Story: Towards a preventive treatment of Alzheimer's disease with multi-functional liposomes. Park K J Control Release; 2017 Jul; 258():254. PubMed ID: 28647031 [No Abstract] [Full Text] [Related]
2. Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease. Mancini S; Balducci C; Micotti E; Tolomeo D; Forloni G; Masserini M; Re F J Control Release; 2017 Jul; 258():121-129. PubMed ID: 28501671 [TBL] [Abstract][Full Text] [Related]
3. Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease. Bana L; Minniti S; Salvati E; Sesana S; Zambelli V; Cagnotto A; Orlando A; Cazzaniga E; Zwart R; Scheper W; Masserini M; Re F Nanomedicine; 2014 Oct; 10(7):1583-90. PubMed ID: 24333591 [TBL] [Abstract][Full Text] [Related]
4. [Alzheimer's disease and cholesterol metabolism]. Michikawa M Seikagaku; 2006 Sep; 78(9):831-9. PubMed ID: 17052019 [No Abstract] [Full Text] [Related]
5. [Cholesterol and Alzheimer's disease]. Kálmán J; Janka Z Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374 [TBL] [Abstract][Full Text] [Related]
6. Medicine. Old drug, new hope for Alzheimer's disease. Strittmatter WJ Science; 2012 Mar; 335(6075):1447-8. PubMed ID: 22442467 [No Abstract] [Full Text] [Related]
8. Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide. Re F; Cambianica I; Sesana S; Salvati E; Cagnotto A; Salmona M; Couraud PO; Moghimi SM; Masserini M; Sancini G J Biotechnol; 2011 Dec; 156(4):341-6. PubMed ID: 21763360 [TBL] [Abstract][Full Text] [Related]
9. [Beta/A4-type amyloid protein in Alzheimer's disease and cerebral amyloid angiopathies]. Hirai S; Okamoto K Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1424-9. PubMed ID: 8245639 [No Abstract] [Full Text] [Related]
10. Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer's disease. Posse de Chaves E Can J Physiol Pharmacol; 2012 Jun; 90(6):753-64. PubMed ID: 22626060 [TBL] [Abstract][Full Text] [Related]
11. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery. Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119 [TBL] [Abstract][Full Text] [Related]
12. [Development of prevention and treatment of Alzheimer's disease: a minireview]. Tabira T Nihon Ronen Igakkai Zasshi; 2004 Jan; 41(1):23-5. PubMed ID: 14999905 [No Abstract] [Full Text] [Related]
13. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease. Rotman M; Welling MM; Bunschoten A; de Backer ME; Rip J; Nabuurs RJ; Gaillard PJ; van Buchem MA; van der Maarel SM; van der Weerd L J Control Release; 2015 Apr; 203():40-50. PubMed ID: 25668771 [TBL] [Abstract][Full Text] [Related]
14. Alzheimer's amyloid story finds its star. Cole GM; Frautschy SA Trends Mol Med; 2006 Sep; 12(9):395-6. PubMed ID: 16880006 [TBL] [Abstract][Full Text] [Related]
15. Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide. Taylor M; Moore S; Mourtas S; Niarakis A; Re F; Zona C; La Ferla B; Nicotra F; Masserini M; Antimisiaris SG; Gregori M; Allsop D Nanomedicine; 2011 Oct; 7(5):541-50. PubMed ID: 21722618 [TBL] [Abstract][Full Text] [Related]
16. [Alzheimer's disease and cholesterol]. Yanagisawa K Seikagaku; 2002 Jun; 74(6):455-60. PubMed ID: 12138706 [No Abstract] [Full Text] [Related]
17. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology. Spangenberg EE; Lee RJ; Najafi AR; Rice RA; Elmore MR; Blurton-Jones M; West BL; Green KN Brain; 2016 Apr; 139(Pt 4):1265-81. PubMed ID: 26921617 [TBL] [Abstract][Full Text] [Related]
18. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry. Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712 [TBL] [Abstract][Full Text] [Related]
19. Preventive effects of a fermented dairy product against Alzheimer's disease and identification of a novel oleamide with enhanced microglial phagocytosis and anti-inflammatory activity. Ano Y; Ozawa M; Kutsukake T; Sugiyama S; Uchida K; Yoshida A; Nakayama H PLoS One; 2015; 10(3):e0118512. PubMed ID: 25760987 [TBL] [Abstract][Full Text] [Related]
20. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease. Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]